(Q39524834)

English

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

scientific article published on December 2011

Statements

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit